ATARA BIOTHERAPEUTICS, INC. Prepaid Expense and Other Assets, Current
ATARA BIOTHERAPEUTICS, INC. (ATRA) had Prepaid Expense and Other Assets, Current of $16.05 million as of 2022-09-30, per its 10-Q filed 2022-11-08.
Discontinued › Notes
us-gaap:PrepaidExpenseAndOtherAssetsCurrent · last filed 2022-11-08
- 2022-09-30: Prepaid Expense and Other Assets, Current $16.05M.
- 2022-06-30: Prepaid Expense and Other Assets, Current $13.69M.
- 2022-03-31: Prepaid Expense and Other Assets, Current $11.57M.
- 2021-12-31: Prepaid Expense and Other Assets, Current $12.37M.
| Period end | Prepaid Expense and Other Assets, Current |
|---|---|
| 2022-09-30 | $16.05M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $13.69M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $11.57M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $12.37M 10-Q · filed 2022-11-08 |
| 2021-09-30 | $12.06M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $18.75M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $19.34M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $21.17M 10-K · filed 2022-02-28 |
| 2020-09-30 | $12.05M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $11.08M 10-Q · filed 2020-08-05 |
| 2020-03-31 | $14.39M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $13.69M 10-K · filed 2021-03-01 |
| 2019-09-30 | $10.30M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $10.81M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $13.09M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $11.66M 10-K · filed 2020-02-27 |
| 2018-09-30 | $8.24M 10-Q · filed 2018-11-06 |
| 2018-06-30 | $7.86M 10-Q · filed 2018-08-01 |
| 2018-03-31 | $6.10M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $5.90M 10-K · filed 2019-02-26 |
| 2017-09-30 | $5.80M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $5.40M 10-Q · filed 2017-08-07 |
| 2017-03-31 | $4.48M 10-Q · filed 2017-05-04 |
| 2016-12-31 | $4.68M 10-K · filed 2018-02-27 |
| 2016-09-30 | $3.89M 10-Q · filed 2016-11-04 |
| 2016-06-30 | $4.13M 10-Q · filed 2016-08-08 |
| 2016-03-31 | $5.14M 10-Q · filed 2016-05-06 |
| 2015-12-31 | $3.92M 10-K · filed 2017-03-09 |
| 2015-09-30 | $5.97M 10-Q · filed 2015-11-06 |
| 2015-06-30 | $5.60M 10-Q · filed 2015-08-07 |
| 2015-03-31 | $3.00M 10-Q · filed 2015-05-11 |
| 2014-12-31 | $1.91M 10-K · filed 2016-03-04 |
| 2014-09-30 | $323.00K 10-Q · filed 2014-11-12 |
| 2013-12-31 | $193.00K 10-K · filed 2015-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |